Literature DB >> 16091624

14-3-3 proteins: a number of functions for a numbered protein.

Dave Bridges1, Greg B G Moorhead.   

Abstract

Many signal transduction events are orchestrated by specific interactions of proteins mediated through discrete phosphopeptide-binding motifs. Although several phosphospecific-binding domains are now known, 14-3-3s were the first proteins recognized to specifically bind a discrete phosphoserine or phosphothreonine motif. The 14-3-3 proteins are a family of ubiquitously expressed, exclusively eukaryotic proteins with an astonishingly large number of binding partners. Consequently, 14-3-3s modulate an enormous and diverse group of cellular processes. The effects of 14-3-3 proteins on their targets can be broadly defined using three categories: (i) conformational change; (ii) physical occlusion of sequence-specific or structural protein features; and (iii) scaffolding. This review will describe the current state of knowledge on 14-3-3 proteins, highlighting several important advances, and will attempt to provide a framework by which 14-3-3 functions can be understood.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091624     DOI: 10.1126/stke.2962005re10

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  126 in total

1.  Polarity-regulating kinase partitioning-defective 1b (PAR1b) phosphorylates guanine nucleotide exchange factor H1 (GEF-H1) to regulate RhoA-dependent actin cytoskeletal reorganization.

Authors:  Yukie Yamahashi; Yasuhiro Saito; Naoko Murata-Kamiya; Masanori Hatakeyama
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

2.  A combination of multisite phosphorylation and substrate sequestration produces switchlike responses.

Authors:  Xinfeng Liu; Lee Bardwell; Qing Nie
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

3.  A robust protocol to map binding sites of the 14-3-3 interactome: Cdc25C requires phosphorylation of both S216 and S263 to bind 14-3-3.

Authors:  Perry M Chan; Yuen-Wai Ng; Ed Manser
Journal:  Mol Cell Proteomics       Date:  2010-12-28       Impact factor: 5.911

4.  Direct interaction between scaffolding proteins RACK1 and 14-3-3ζ regulates brain-derived neurotrophic factor (BDNF) transcription.

Authors:  Jérémie Neasta; Patrick A Kiely; Dao-Yao He; David R Adams; Rosemary O'Connor; Dorit Ron
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

5.  Functional specialization of beta-arrestin interactions revealed by proteomic analysis.

Authors:  Kunhong Xiao; Daniel B McClatchy; Arun K Shukla; Yang Zhao; Minyong Chen; Sudha K Shenoy; John R Yates; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

6.  14-3-3 proteins tune non-muscle myosin II assembly.

Authors:  Hoku West-Foyle; Priyanka Kothari; Jonathan Osborne; Douglas N Robinson
Journal:  J Biol Chem       Date:  2018-03-16       Impact factor: 5.157

7.  Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution.

Authors:  Liam J Holt; Brian B Tuch; Judit Villén; Alexander D Johnson; Steven P Gygi; David O Morgan
Journal:  Science       Date:  2009-09-25       Impact factor: 47.728

8.  14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly.

Authors:  Payaningal R Somanath; Tatiana V Byzova
Journal:  J Cell Physiol       Date:  2009-02       Impact factor: 6.384

9.  14-3-3γ, a novel regulator of the large-conductance Ca2+-activated K+ channel.

Authors:  Shan Chen; Xiuyan Feng; Xinxin Chen; Zhizhi Zhuang; Jia Xiao; Haian Fu; Janet D Klein; Xiaonan H Wang; Robert S Hoover; Douglas C Eaton; Hui Cai
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

10.  Mechanisms mediating the effects of alcohol and HIV anti-retroviral agents on mTORC1, mTORC2 and protein synthesis in myocytes.

Authors:  Ly Q Hong-Brown; Abid A Kazi; Charles H Lang
Journal:  World J Biol Chem       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.